What are the differential diagnoses for a large café‑au‑lait macule present since birth?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis of Large Café-au-Lait Patch Present Since Birth

A large café-au-lait macule present since birth requires systematic evaluation for neurofibromatosis type 1 (NF1), McCune-Albright syndrome, congenital melanocytic nevus, and other genetic syndromes, with the specific morphology, distribution pattern, and associated features guiding the differential diagnosis.

Primary Differential Diagnoses

Neurofibromatosis Type 1 (NF1)

  • Most common syndrome associated with café-au-lait macules in children, affecting 1 in 2,000-3,000 individuals 1, 2
  • Café-au-lait spots in NF1 are typically well-circumscribed, evenly pigmented, round to oval macules 3
  • Diagnosis requires ≥2 NIH criteria: ≥6 café-au-lait spots (≥5mm prepubertal), axillary/inguinal freckling (Crowe's sign), neurofibromas, Lisch nodules, optic glioma, distinctive bone lesions, or first-degree relative with NF1 1, 2
  • Critical examination points: Look for axillary or inguinal freckling (highly specific, appears within first 3 years), palpate for cutaneous/subcutaneous neurofibromas, perform slit-lamp examination for Lisch nodules 1, 2
  • NF1 carries an 8-15 year reduction in life expectancy due to malignant peripheral nerve sheath tumors and cardiovascular disease 2

McCune-Albright Syndrome

  • Pathognomonic feature: Café-au-lait macules with irregular, jagged "coast of Maine" borders arranged in a Blaschko-linear pattern in broad bands 4, 5
  • This linear arrangement reflects the genetic mosaicism characteristic of the disease 4
  • Classic triad: café-au-lait spots, fibrous dysplasia of bone, and endocrine disorders (especially precocious puberty) 4
  • Key distinction: The irregular borders and segmental distribution are diagnostic even before bone or endocrine manifestations appear 4
  • Diagnosis can be confirmed by genetic testing showing arginine substitution at position 201 of Gs alpha protein 4

Congenital Melanocytic Nevus (CMN)

  • Large CMN can present as raised, hypertrichotic, verrucous, cerebriform, or papillated lesions present at birth 6
  • Size classification matters: Small (<1.5cm), medium (1.5-20cm), large (>20cm), or giant (>40cm or >5% body surface area) 6
  • Patients with large, giant, or multiple CMN should establish care with pediatric dermatology in the neonatal period 6
  • Critical surveillance: Monitor for proliferative nodules (benign but can mimic melanoma) and true melanoma risk, which can occur in skin or CNS 6
  • MRI screening for neurocutaneous melanosis is recommended for giant CMN, multiple medium CMN, or ≥10 satellite lesions 6

Mastocytoma

  • Solitary mastocytomas can be several centimeters in diameter, resembling large pigmented patches 6
  • Typically present at birth or develop within one week of life 6
  • Diagnostic feature: Positive Darier's sign (urtication and flare upon rubbing the lesion) 6
  • Can vesiculate and blister, particularly in infancy 6
  • Most cases resolve by puberty, though persistent lesions occur in adults 6

Secondary Differential Diagnoses

RASopathies (Noonan, Costello, CBL Syndromes)

  • Present with café-au-lait macules plus dysmorphic facial features, congenital heart defects, short stature, and cryptorchidism 1, 2
  • Lack the tumor risks associated with NF1 2

Legius Syndrome (SPRED1 mutations)

  • Mimics NF1 with café-au-lait macules and axillary/inguinal freckling 2, 7
  • Critical distinction: Lacks neurofibromas, optic gliomas, and tumor risks 2, 7
  • Normal life expectancy, unlike NF1 2
  • Genetic testing (SPRED1 vs. NF1 gene) definitively distinguishes these conditions 2

Constitutional Mismatch Repair Deficiency (CMMRD)

  • Can mimic NF1 with café-au-lait macules, freckling, and even neurofibromas in one-third of patients 2
  • Red flags: Hypopigmented spots in addition to café-au-lait spots, pilomatrixomas (calcifying skin tumors), family history of childhood cancers 1, 2
  • Extremely high cancer risk (childhood leukemia, brain tumors, GI malignancies) 2

Nijmegen Breakage Syndrome (NBS)

  • Café-au-lait macules occur alongside microcephaly, dysmorphic facial features, growth deficiency, and immunodeficiency 6
  • Approximately 50% show borderline to mild intellectual disability 6
  • High risk of lymphomas and leukemias 6

Algorithmic Approach to Evaluation

Step 1: Document Lesion Characteristics

  • Measure and count all café-au-lait spots precisely (≥6 spots ≥5mm meets one NIH criterion for NF1) 1, 2
  • Assess borders: Smooth/regular (NF1, Legius) vs. irregular/jagged (McCune-Albright) 4, 5
  • Evaluate distribution: Random/scattered vs. Blaschko-linear/segmental (McCune-Albright) 4, 5
  • Examine texture: Flat/smooth vs. raised/verrucous/hairy (CMN) 6
  • Test Darier's sign: Rub lesion to check for urtication (mastocytoma) 6

Step 2: Comprehensive Physical Examination

  • Skin: Examine entire body for axillary/inguinal freckling, neurofibromas, hypopigmented spots, pilomatrixomas 1, 2
  • Eyes: Slit-lamp examination for Lisch nodules (NF1) 1, 2
  • Dysmorphic features: Facial features, body proportions, cardiac examination (RASopathies) 1, 2
  • Neurologic: Developmental assessment, head circumference (NBS) 6
  • Endocrine: Signs of precocious puberty (McCune-Albright) 4

Step 3: Family History Assessment

  • Obtain three-generation family history examining for café-au-lait spots, neurofibromatosis, childhood cancers, learning disabilities 1
  • Family history of childhood cancers suggests CMMRD 1, 2

Step 4: Determine Referral Needs

  • Immediate genetics referral if: ≥2 NIH criteria for NF1, developmental delays/hypotonia, dysmorphic features suggesting RASopathy, family history of childhood cancers, or café-au-lait spots plus childhood leukemia/brain tumors 1, 2
  • Pediatric dermatology referral for large/giant CMN in neonatal period 6
  • Specialized NF1 clinic for confirmed or suspected NF1 2

Step 5: Surveillance Protocol

  • For isolated large café-au-lait spot without other features: Close clinical follow-up every 3-6 months during first 3 years of life, then annually after age 3-5 years 1
  • For suspected NF1: Annual comprehensive examination, blood pressure monitoring, neurologic assessment 2
  • For large/giant CMN: Serial photographs, palpation for nodules, MRI screening if indicated 6

Critical Pitfalls to Avoid

  • Do not dismiss a single large café-au-lait spot as benign without thorough evaluation—McCune-Albright can present with a single segmental lesion before other manifestations appear 4
  • Do not confuse Legius syndrome with NF1—Legius patients lack tumor risks and require different surveillance 2, 7
  • Do not delay referral in children with café-au-lait spots plus developmental delays, hypotonia, or leukemia—these suggest high-risk syndromic diagnoses requiring specialized care 1, 2
  • Do not overlook palpation of café-au-lait spots and surrounding skin—deep nodules in CMN can indicate melanoma without surface color change 6
  • Do not assume all large pigmented patches are café-au-lait spots—mastocytomas can mimic them but have positive Darier's sign 6

Parent Education Priorities

Counsel parents to monitor for and report: 1, 2

  • New skin freckling in armpits or groin
  • Skin lumps or bumps
  • Vision changes
  • Developmental concerns
  • Rapid growth, bleeding, or pain in the lesion

References

Guideline

Evaluation and Management of Isolated Multiple Café au Lait Spots in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management and Evaluation of Significant Café au Lait Spots

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The diagnostic and clinical significance of café-au-lait macules.

Pediatric clinics of North America, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Familial Benign Café au Lait Macules

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.